Oak Thistle LLC’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Buy
+37,529
New +$3.09M 0.29% 118
2024
Q4
Sell
-30,245
Closed -$2M 447
2024
Q3
$2M Buy
+30,245
New +$2.2M 0.65% 18
2023
Q4
Sell
-10,100
Closed -$700K 507
2023
Q3
$700K Buy
+10,100
New +$812K 0.21% 212
2023
Q2
Sell
-8,121
Closed -$672K 414
2023
Q1
$672K Buy
+8,121
New +$638K 0.4% 71
2022
Q2
Sell
-7,749
Closed -$912K 257
2022
Q1
$912K Buy
+7,749
New +$869K 0.48% 40

Other funds holding EW

Oak Thistle LLC's EW Position: Q1 2026 in Review

Oak Thistle LLC opened a new position in Edwards Lifesciences (EW) in Q1 2026: 37,529 shares worth $3.01M. The stake represents 0.29% of the portfolio and ranks #118 among its holdings. This is a return to the name: Oak Thistle LLC previously reported a position in EW as recently as Q3 2024.

Oak Thistle LLC first reported a position in EW in Q1 2022 and has held it in 5 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Oak Thistle LLC held 37,529 shares of Edwards Lifesciences worth $3.01M as of Q1 2026.
  • Edwards Lifesciences was a new Oak Thistle LLC position in Q1 2026.
  • Edwards Lifesciences made up 0.29% of Oak Thistle LLC's portfolio in Q1 2026, its #118 holding.
  • Oak Thistle LLC first reported a position in Edwards Lifesciences in Q1 2022 and has held it in 5 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Oak Thistle LLC's 13F filing for Q1 2026, filed 13 Apr 2026.